SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-005893
Filing Date
2023-04-13
Accepted
2023-04-13 17:24:34
Documents
12
Period of Report
2023-04-07
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 8-K rsls-20230407x8k.htm   iXBRL 8-K 35524
  Complete submission text file 0001558370-23-005893.txt   152780

Data Files

Seq Description Document Type Size
2 EX-101.SCH rsls-20230407.xsd EX-101.SCH 3105
3 EX-101.LAB rsls-20230407_lab.xml EX-101.LAB 15240
4 EX-101.PRE rsls-20230407_pre.xml EX-101.PRE 9781
6 EXTRACTED XBRL INSTANCE DOCUMENT rsls-20230407x8k_htm.xml XML 4623
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 23819202
SIC: 3841 Surgical & Medical Instruments & Apparatus